BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15230209)

  • 1. [Lymphocyte and lymphocyte subsets in pleural fluid--comparison of malignant and non-malignant disorders].
    Klimiuk J; Domagała-Kulawik J; Krenke R; Chazan R
    Pol Arch Med Wewn; 2004 Mar; 111(3):291-6. PubMed ID: 15230209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte subpopulations analysis in pleural fluid and peripheral blood in patients with lymphocytic pleural effusions.
    Albera C; Mabritto I; Ghio P; Scagliotti GV; Pozzi E
    Respiration; 1991; 58(2):65-71. PubMed ID: 1677776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric study of T-cell subsets in lymphocytic pleural effusions.
    Khalil RY; Khalil MM
    Cytometry; 1997 Aug; 30(4):204-5. PubMed ID: 9298840
    [No Abstract]   [Full Text] [Related]  

  • 4. Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid.
    Scherpereel A; Grigoriu BD; Noppen M; Gey T; Chahine B; Baldacci S; Trauet J; Copin MC; Dessaint JP; Porte H; Labalette M
    BMC Cancer; 2013 Jul; 13():324. PubMed ID: 23816056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation-induced cell death of memory CD8+ T cells from pleural effusion of lung cancer patients is mediated by the type II Fas-induced apoptotic pathway.
    Prado-Garcia H; Romero-Garcia S; Morales-Fuentes J; Aguilar-Cazares D; Lopez-Gonzalez JS
    Cancer Immunol Immunother; 2012 Jul; 61(7):1065-80. PubMed ID: 22159518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant pleural effusions due to small cell carcinoma of the lung. An immunocytochemical cell-surface analysis of lymphocytes and tumor cells.
    Guzman J; Bross KJ; Costabel U
    Acta Cytol; 1990; 34(4):497-501. PubMed ID: 2165344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte subsets in peripheral blood and pleural fluid.
    Lucivero G; Pierucci G; Bonomo L
    Eur Respir J; 1988 Apr; 1(4):337-40. PubMed ID: 3260873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of immunophenotype of lymphoid cells isolated from malignant pleural effusions.
    Jezewska E; Sikora J; Słowik-Gabryelska A; Zeromski J
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):51-6. PubMed ID: 8239908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculous effusion: ADA activity correlates with CD4+ cell numbers in the fluid and the pleura.
    Gaga M; Papamichalis G; Bakakos P; Latsi P; Samara I; Koulouris NG; Alchanatis N; Orphanidou D
    Respiration; 2005; 72(2):160-5. PubMed ID: 15824526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of pleural effusions using flow cytometry.
    Ceyhan BB; Demiralp E; Celikel T
    Respiration; 1996; 63(1):17-24. PubMed ID: 8833988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculous pleural effusions: lymphocyte phenotypes in comparison with other lymphocyte-rich effusions.
    Guzman J; Bross KJ; Würtemberger G; Freudenberg N; Costabel U
    Diagn Cytopathol; 1989; 5(2):139-44. PubMed ID: 2673702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PD-L1/PD-1 pathway promotes dysfunction, but not "exhaustion", in tumor-responding T cells from pleural effusions in lung cancer patients.
    Prado-Garcia H; Romero-Garcia S; Puerto-Aquino A; Rumbo-Nava U
    Cancer Immunol Immunother; 2017 Jun; 66(6):765-776. PubMed ID: 28289860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominance of Th17 over regulatory T-cells in pleural effusions of patients with lung cancer implicates a proinflammatory profile.
    Prado-Garcia H; Romero-Garcia S; Rumbo-Nava U; Lopez-Gonzalez JS
    Anticancer Res; 2015 Mar; 35(3):1529-35. PubMed ID: 25750307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells in malignant pleural effusions subsequent to lung carcinoma and their impact on the course of the disease.
    Budna J; Spychalski Ł; Kaczmarek M; Frydrychowicz M; Goździk-Spychalska J; Batura-Gabryel H; Sikora J
    Immunobiology; 2017 Mar; 222(3):499-505. PubMed ID: 27773662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte populations in tuberculous pleural effusions.
    San José ME; Valdés L; Saavedra MJ; De Vega JM; Alvarez D; Viñuela J; Penela P; Valle JM; Seoane R
    Ann Clin Biochem; 1999 Jul; 36 ( Pt 4)():492-500. PubMed ID: 10456212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-16 in tuberculous and malignant pleural effusions.
    Qin XJ; Shi HZ; Huang ZX; Kang LF; Mo WN; Wu C
    Eur Respir J; 2005 Apr; 25(4):605-11. PubMed ID: 15802332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte subpopulations in middle ear effusions: flow cytometry analysis.
    Skotnicka B; Stasiak-Barmuta A; Hassmann-Poznanska E; Kasprzycka E
    Otol Neurotol; 2005 Jul; 26(4):567-71. PubMed ID: 16015148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-lymphocyte subsets in pleural fluids: discrimination according to traditional and monoclonal antibody-defined markers.
    Kochman S; Bernard J; Lavaud F; Cazabat A; Dubois de Montreynaud JM
    Eur J Respir Dis; 1984 Nov; 65(8):586-91. PubMed ID: 6240409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant and tuberculous pleural effusions: immunophenotypic cellular characterization.
    Aguiar LM; Antonangelo L; Vargas FS; Zerbini MC; Sales MM; Uip DE; Saldiva PH
    Clinics (Sao Paulo); 2008 Oct; 63(5):637-44. PubMed ID: 18925324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.